Company Analysis Jazz Pharmaceuticals plc
1. Summary
Advantages
- The stock's return over the last year (12.7%) is higher than the sector average (-21.54%).
- The company's current efficiency (ROE=11.1%) is higher than the sector average (ROE=9.78%)
Disadvantages
- Price (146.17 $) is higher than fair price (60.67 $)
- Dividends (0%) are below the sector average (0.5351%).
- Current debt level 50.31% has increased over 5 years from 0.6028%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Jazz Pharmaceuticals plc | Healthcare | Index | |
|---|---|---|---|
| 7 days | 8.3% | -20.4% | -5.4% |
| 90 days | 19.2% | -22.2% | -12.5% |
| 1 year | 12.7% | -21.5% | 8.7% |
JAZZ vs Sector: Jazz Pharmaceuticals plc has outperformed the "Healthcare" sector by 34.23% over the past year.
JAZZ vs Market: Jazz Pharmaceuticals plc has outperformed the market by 4.04% over the past year.
Stable price: JAZZ is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: JAZZ with weekly volatility of 0.2442% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (146.17 $) is higher than the fair price (60.67 $).
Price is higher than fair: The current price (146.17 $) is 58.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (21.06) is lower than that of the sector as a whole (57.27).
P/E vs Market: The company's P/E (21.06) is lower than that of the market as a whole (49.14).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.34) is lower than that of the sector as a whole (4.64).
P/BV vs Market: The company's P/BV (2.34) is lower than that of the market as a whole (3.44).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.28) is lower than that of the sector as a whole (33.44).
P/S vs Market: The company's P/S indicator (2.28) is lower than that of the market as a whole (10.29).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (10.27) is higher than that of the sector as a whole (-17.68).
EV/Ebitda vs Market: The company's EV/Ebitda (10.27) is lower than that of the market as a whole (25.46).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 14.71% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (14.71%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (106.41%).
5.4. ROE
ROE vs Sector: The company's ROE (11.1%) is higher than that of the sector as a whole (9.78%).
ROE vs Market: The company's ROE (11.1%) is higher than that of the market as a whole (8.96%).
5.5. ROA
ROA vs Sector: The company's ROA (3.64%) is higher than that of the sector as a whole (0.33%).
ROA vs Market: The company's ROA (3.64%) is lower than that of the market as a whole (6.33%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-3.25%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (-3.25%) is lower than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5351%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 07.03.2025 | Henderson Mary Elizabeth Officer |
Purchase | 139 | 180 005 | 1 295 |
| 27.02.2025 | Carr Patricia Officer |
Purchase | 139 | 228 099 | 1 641 |
| 02.12.2024 | COZADD BRUCE C Officer |
Purchase | 121.17 | 242 340 | 2 000 |
| 06.08.2024 | Cook Jennifer E. Director |
Purchase | 111 | 341 325 | 3 075 |
| 06.08.2024 | McSharry Heather Ann Director |
Purchase | 111 | 341 325 | 3 075 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
